Consensus HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Real-time Estimate Cboe BZX 10:36:18 2024-03-28 am EDT 5-day change 1st Jan Change
333.2 USD +0.45% Intraday chart for HCA Healthcare, Inc. +1.36% +23.14%

Evolution of the average Target Price on HCA Healthcare, Inc.

Price target over the last 5 years

History of analyst recommendation changes

cecc68e3526976a532.0Y9_fJC75ae-FDFFPcvphLZCKUruDdHjgXdcPPMlnMY.newbCMjdit3RRUgAZaPE1tglXjmBRqC2zSApDqlkr6GH0E8P2-iU7skifA~7a6535ef16af1b31e4027e7d835ce36d
ANALYST RECOMMENDATIONS : Nasdaq, Stellantis, Clorox, Ulta Beauty, Standard Chartered... Our Logo
Hca Healthcare Insider Sold Shares Worth $400,057, According to a Recent SEC Filing MT
ANALYST RECOMMENDATIONS : Doordash, Microsoft, Roblox, Uber, Redrow... Our Logo
UBS Adjusts HCA Healthcare Price Target to $348 From $305, Maintains Buy Rating MT
Deutsche Bank Raises HCA Healthcare Price Target to $330 From $280, Maintains Buy Rating MT
Raymond James Raises Price Target on HCA Healthcare to $330 From $300, Maintains Outperform Rating MT
Oppenheimer Raises HCA Healthcare Price Target to $330 From $315, Maintains Outperform Rating MT
RBC Raises Price Target on HCA Healthcare to $322 From $308 Amid 'Impressive' Q4 Results, 2024 Guidance; Outperform Kept MT
RBC Raises Price Target on HCA Healthcare to $308 From $284, Keeps Outperform Rating MT
Bernstein Downgrades HCA Healthcare to Market Perform From Outperform, Price Target is $301 MT
Goldman Sachs Downgrades HCA Healthcare to Neutral From Buy, Cuts Price Target to $271 From $281 MT
Argus Cuts HCA Healthcare Price Target to $290 From $310, Maintains Buy Rating MT
JPMorgan Adjusts Price Target on HCA Healthcare to $265 From $313, Maintains Neutral Rating MT
ANALYST RECOMMENDATIONS : Best Buy, Diageo, Eli Lilly, Estee Lauder, Home Depot... Our Logo
Goldman Sachs Cuts Price Target on HCA Healthcare to $281 From $329, Maintains Buy Rating MT
Deutsche Bank Cuts HCA Healthcare's Price Target to $280 From $310, Maintains Buy Rating MT
Wells Fargo Adjusts HCA Healthcare's Price Target to $254 From $267, Keeps Equalweight Rating MT
Mizuho Adjusts HCA Healthcare's Price Target to $275 From $325, Keeps Buy Rating MT
Stephens Cuts HCA Healthcare's Price Target to $280 From $310, Keeps Overweight Rating MT
UBS Adjusts HCA Healthcare Price Target to $305 From $323, Maintains Buy Rating MT
Raymond James Cuts Price Target on HCA Healthcare to $280 From $320, Maintains Outperform Rating MT
RBC Cuts Price Target on HCA Healthcare to $284 From $315 After Q3 Adjusted Earnings Miss, Keeps Outperform Rating MT
Baptista Initiates HCA Healthcare at Outperform Rating With $281.20 Price Target MT
Wells Fargo Cuts Price Target on HCA Healthcare to $267 From $275, Maintains Equal-Weight Rating MT
ANALYST RECOMMENDATIONS : Blackstone, Morgan Stanley, Netflix, Tesla, Union Pacific... Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
331.7 USD
Average target price
337 USD
Spread / Average Target
+1.61%
High Price Target
378 USD
Spread / Highest target
+13.96%
Low Price Target
285 USD
Spread / Lowest Target
-14.08%

Consensus detail

Consensus revision (last 18 months)

Analysts covering HCA Healthcare, Inc.

UBS
Deutsche Bank Securities
Raymond James
Oppenheimer
RBC Capital Markets
Bernstein
Goldman Sachs
Argus
JPMorgan Chase
Wells Fargo Securities
Mizuho Securities
Stephens Inc.
Baptista Research
Credit Suisse
Barclays
Truist Securities
Jefferies & Co.
Citigroup
BofA Securities
TD Cowen
Loop Capital
Cantor Fitzgerald
Cowen
SVB Securities LLC
BMO Capital
SVB Leerink
Seaport Global Securities
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings